A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis

Ivan R. Schwab, Mitchell Friedlaender, James P McCulley, Steven J. Lichtenstein, C. Thomas Moran, Mark Abelson, Gavin Bahadur, Richard Braunstein, Robert Caine, Timothy Cavanaugh, Steven Dell, Peter Donshik, Norman Levy, Bernard Milstein, Thomas Mundorf, Terrence O'Brien, Steven Prepas, Robert Reidy, Kenneth Sall, Alan SugarShailaja Valluri, Francis Wapner, Thomas Wolf

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint Dive into the research topics of 'A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis'. Together they form a unique fingerprint.

Medicine & Life Sciences